Grifols, S.A.
$5.30+0.00%(+$0.00)
TickerSpark Score
67/100
93
Valuation
70
Profitability
70
Growth
72
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GIKLY research report →
52-Week Range10% of range
Low $5.05
Current $5.30
High $7.49
Companywww.grifols.com
Grifols, S. A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives.
- CEO
- Jose Ignacio Abia Buenache
- IPO
- 2010
- Employees
- 23,833
- HQ
- Barcelona, ES
Price Chart
+9.28% · this period
Valuation
- Market Cap
- $13.93B
- P/E
- 15.68
- P/S
- 0.88
- P/B
- 1.19
- EV/EBITDA
- 10.80
- Div Yield
- 1.57%
Profitability
- Gross Margin
- 37.68%
- Op Margin
- 16.89%
- Net Margin
- 5.58%
- ROE
- 7.88%
- ROIC
- 5.49%
Growth & Income
- Revenue
- $7.52B · 4.32%
- Net Income
- $386.03M · 146.00%
- EPS
- $0.28 · 143.48%
- Op Income
- $1.25B
- FCF YoY
- 41.51%
Performance & Tape
- 52W High
- $7.49
- 52W Low
- $5.05
- 50D MA
- $5.35
- 200D MA
- $6.35
- Beta
- 1.17
- Avg Volume
- 47
Get TickerSpark's AI analysis on GIKLY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our GIKLY Coverage
We haven't published any research on GIKLY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GIKLY Report →Similar Companies
ALPMF+8.47%
Astellas Pharma Inc.
$14.54
ORINY+0.00%
Orion Oyj
$37.99
ALPMY-0.16%
Astellas Pharma Inc.
$14.54
BMXXY+0.00%
bioMérieux S.A.
$8.30
CHJTF+0.00%
CSPC Pharmaceutical Group Limited
$1.05
WXXWY+1.17%
WuXi Biologics (Cayman) Inc.
$8.40
FMCQF+0.00%
Fresenius Medical Care AG & Co. KGaA
$42.00
WXIBF-0.71%
WuXi Biologics (Cayman) Inc.
$4.18